34666611000001109: Sarilumab (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

104713001000001110 Sarilumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

104713101000001111 Sarilumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sarilumab	Is a	Substance with interleukin receptor antagonist mechanism of action	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sarilumab 150mg/1.14ml solution for injection pre-filled disposable devices	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 150mg/1.14ml solution for injection pre-filled syringes	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 200mg/1.14ml solution for injection pre-filled syringes	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 150mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme)	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 200mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme)	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 150mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme)	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 200mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme)	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 150mg/1.14ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 200mg/1.14ml solution for injection pre-filled syringes 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Sarilumab 150mg/1.14ml solution for injection pre-filled syringes 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 150mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme) 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 200mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme) 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 150mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme) 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier
Kevzara 200mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme) 2 pre-filled disposable injection	Has specific active ingredient	False	Sarilumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets